Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
Milestone Pharmaceuticals’ $34.5 Million Common Shares Offering
Crescent Energy’s $126 Million Common Stock Offering
Vinson & Elkins represented Crescent Energy Company in the offering, Simpson Thacher & Bartlett represented the underwriters. Debevoise & Plimpton and Richards, Layton & Finger represented...
Skye Bioscence’s $40 Million Private Placement Equity Financing
Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction. Skye Bioscience, Inc. (OTCQB:...
AppLovin’ Common Stock Secondary Offering and Share Repurchase
Wilson Sonsini Goodrich & Rosati advised AppLovin Corporation on the deal, and Fenwick & West advised the underwriters. AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”),...
Skye Bioscience’s $50.25 Million Private Placement
Paul Hastings LLP advised the lead placement agent and the placement agent. Skye Bioscience, Inc. (OTCQB: SKYE), a clinical stage biotechnology company focused on the discovery,...
Helix’s $300 Million Senior Notes Offering
Baker Botts, Maslon, Locke Lord, Pinsent Masons and Maples and Calder represented Helix Energy Solutions Group, Inc. in the offering, while Simpson Thacher & Bartlett represented...
Aligos Therapeutics’ $92 Million Private Placement
Davis Polk & Wardwell advised Piper Sandler, acted sole placement agent, on the private placement. Aligos Therapeutics, Inc. announced its private placement $92 million private placement of...
ALX Oncology’s $63 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
Immunovant’s US$450 Million Common Stock Financing
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
CymaBay Therapeutics’ $258.75 Million Follow-On Offering
Cooley advised CymaBay, and Paul Hastings advised the representatives of the underwriters. CymaBay Therapeutics, Inc. announced its $258.75 million follow-on offering of common stock and pre-funded...
Klaviyo’s $576 Million Initial Public Offering
Goodwin Procter advised Klaviyo, and Sidley Austin advised the underwriters on the offering. Klaviyo, Inc. announced the pricing of its initial public offering of 19,200,000 shares of...
Instacart’s $660 Million Initial Public Offering
Cooley advised Instacart, and Latham & Watkins advised the underwriters. Maplebear Inc. d/b/a Instacart announced the pricing of its initial public offering of 22,000,000 shares of its...